site stats

Gynecol. oncol

WebMay 27, 2024 · Gynecologic Oncology has an h-index of 173.It means 173 articles of this journal have more than 173 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been … WebA phase II trial of radiation therapy and weekly cisplatin chemotherapy for the treatment of locally-advanced squamous cell carcinoma of the vulva: a gynecologic oncology group …

Home - GynecolOncol

WebApr 13, 2024 · These specific outcomes suggest short term mortality may be associated with hypoalbuminemia. The purpose of our study was to evaluate whether reduced pre-operative albumin levels in patients undergoing surgery for gynecologic malignancy are associated with increased 90-day and 1-year mortality in a tertiary care center in XXXXX. WebApr 14, 2024 · Covariates. We reviewed our prospectively maintained institutional gynecological cancer database for demographic characteristics (age, height, and weight), clinical characteristics (treatment methods, FIGO stage, histological type and grade, residual disease status, and malignant ascites), Eastern Cooperative Oncology Group (ECOG) … barry kz hund https://genejorgenson.com

Frontiers Treatment options for recurrent platinum-resistant …

WebVaginal cuff length during radical hysterectomy is a prognostic factor for stage IB-IIA cervical cancer: a retrospective study Na Zuo,1,* Hongzhen Hu,1,2,* Niresh Thapa,1,3 Zhen Li,1 Daqiong Jiang,1 Xiangyu Meng,4 Jing Yang,1 Xiaoxing Chen,5 Hongbing Cai1 1Department of Gynecological Oncology, Zhongnan Hospital of Wuhan University, Hubei Cancer … WebGynecologic Oncology Impact Factor, IF, number of article, detailed information and journal factor. ISSN: 0090-8258. ... Journal Impact. Enter journal title, issn or abbr in this box to search. Gynecologic Oncology. Journal Abbreviation: GYNECOL ONCOL Journal ISSN: 0090-8258. Year: Impact Factor (IF) Total Articles: Total Cites: 2024 (2024 ... WebA phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. … barry landau obituary

Why have ovarian cancer mortality rates declined? Part I. Incidence

Category:Home Page: Gynecologic Oncology

Tags:Gynecol. oncol

Gynecol. oncol

Chemotherapie Überarbeitete Leitlinie gibt Orientierung ...

WebMyometrial invasion (MI) is a parameter currently used in transvaginal ultrasound (TVS) in endometrial cancer (EC) to determine local staging; however, without molecular diagnostics, it is insufficient for the selection of high-risk cases, i.e., those with a high risk of lymph node metastases (LNM). The study’s objective was to answer the question of which TVS … WebLate-Breaking Abstract 5: Results from a 2nd interim OS analysis in OCEANS: A randomized phase 3 trial of gemcitabine (G), carboplatin (C) and bevacizumab (BV) followed by BV to disease progression in patients with platinum-sensitive recurrent epithelial ovarian (OC), primary peritoneal (PPC), or fallopian tube cancer (FTC) C. Aghajanian, S ...

Gynecol. oncol

Did you know?

WebJun 9, 2024 · Gynecol Oncol. 2012. PMID: 22446621 Clinical Trial. Ovarian Sertoli-Leydig cell tumor: a report of seven cases and a review of the literature. Xiao H, Li B, Zuo J, Feng X, Li X, Zhang R, Wu L. Xiao H, et al. Gynecol Endocrinol. 2013 Mar;29(3):192-5. doi: 10.3109/09513590.2012.738723. Epub 2012 Nov 23.

WebRachel Ruskin, M.D. Associate Clinical Professor, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology. Print PDF. Save contact. To see if Rachel Ruskin is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284). Gynecology Oncology. WebAbout Gynecologic Oncology. Approximately 80,000 women in the United States are diagnosed annually with some form of gynecologic cancer – Gynecologic Oncologists …

WebObjective: Indoleamine 2,3-dioxygenase-1 (IDO1) is a key regulator of immune tolerance in ovarian cancer. This study investigated efficacy and safety of the IDO1 enzyme inhibitor epacadostat versus tamoxifen in patients with biochemical-only recurrence (CA-125 elevation) following complete remission after first-line chemotherapy for advanced … WebGynecologic Oncology, an international journal, is devoted to the publication of clinical and investigative articles that concern tumors of the female reproductive tract. Investigations … Latest issue - Gynecologic Oncology Journal ScienceDirect.com by Elsevier All issues - Gynecologic Oncology Journal ScienceDirect.com by Elsevier Note to users:. Articles in press are peer reviewed, accepted articles to be … Special issues and article collections - Gynecologic Oncology Journal … View Full Editorial Board - Gynecologic Oncology Journal ScienceDirect.com … View All News - Gynecologic Oncology Journal ScienceDirect.com by Elsevier

WebDec 21, 2024 · Affiliations 1 Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: [email protected]. 2 Department of Obstetrics and Gynecology, University of Washington, Seattle, WA, USA.; 3 Department of Obstetrics and Gynecology, The Jikei University School of Medicine, Tokyo, Japan.; 4 Department of Oncology, …

WebGynecologic Oncology, an international journal, is devoted to the publication of clinical and investigative articles that concern tumors of the female reproductive tract. Investigations … barry landau 60 minutesWebA gynecologic oncologist is a specialty gynecologist trained in oncology (the medical field that deals with tumors and cancer), who diagnoses, treats and performs surgery on … suzuki xl7 specsWebPhase II trial of alternating courses of megestrol acetate and tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study Gynecol Oncol . 2004 … suzuki xl7 service manualWebObjective: The efficacy and safety of olaparib, an oral poly(ADP-ribose) polymerase (PARP) inhibitor, was investigated in a subgroup of patients with germline BRCA1/2 mutated (gBRCA1/2m) advanced ovarian cancer who had received ≥3 prior lines of chemotherapy. Primary data from this Phase II study (Study 42, ClinicalTrials.govNCT01078662) have … barry lapidus paramountWebMar 13, 2024 · Gynecol Oncol 20 (3): 346-53, 1985. [PUBMED Abstract] Stock RG, Chen AS, Seski J: A 30-year experience in the management of primary carcinoma of the vagina: analysis of prognostic factors and treatment modalities. barry lapidusWebAbstract. Objectives: Assess outcomes of a clinical cohort of patients with endometrioid endometrial cancer (EEC) harboring somatic POLE exonuclease domain mutations (EDMs). Methods: Patients were consented to a protocol of tumor-normal massively parallel sequencing of 410-468 cancer related genes. EECs subjected to sequencing from 2014 … barry lakeWebGynecol Oncol. 2014 Jun;133(3):624-31. doi: 10.1016/j.ygyno.2014.02.038. Epub 2014 Mar 4. Authors Alison Davis 1 , Anna V Tinker 2 , Michael Friedlander 3 Affiliations 1 The Canberra Hospital and The Australian National University, Canberra, Australia. Electronic address: [email protected]. ... barry landau dvm